Imeik Technology Development Co.,Ltd. (SHE:300896)

Market Cap	51.45B
Revenue (ttm)	2.88B
Net Income (ttm)	1.87B
Shares Out	301.43M
EPS (ttm)	6.22
PE Ratio	27.44
Forward PE	24.34
Dividend	3.80 (2.23%)
Ex-Dividend Date	Apr 30, 2025

Volume	2,057,890
Average Volume	2,709,703
Open	171.00
Previous Close	170.69
Day's Range	169.83 - 174.40
52-Week Range	132.81 - 282.72
Beta	1.38
RSI	39.30
Earnings Date	Apr 25, 2025

About SHE:300896

Imeik Technology Development Co.,Ltd. engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China. The company offers aesthetic medicine products, including cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere, poly facial implant thread, medical sodium hyaluronate-hydroxypropyl methylcellulose gel, sodium hyaluronate composite solution for injection, modified sodium hyaluronate gel for injection, and medical PVA gel ball-sodium hyaluronate-hydroxypropyl methylcellulose ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2004
• Employees: 1,223
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300896

Financial Performance

In 2024, SHE:300896's revenue was 3.03 billion, an increase of 5.45% compared to the previous year's 2.87 billion. Earnings were 1.96 billion, an increase of 5.33%.